Volume Outcome Relationships and Effects
Part of paid clinical trials in Richardson, Texas.
- Sponsor
- Methodist Health System
- Study ID
- NCT06343597
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
This is a retrospective analysis to assess if high-volume hospital facilities experience greater or lesser rates of incidence in patients with esophageal cancer than low-volume facilities.
Key Dates
- Start date
- Jun 15, 2020
- Status verified
- Jan 2026
- Primary completion
- Jun 15, 2027
- Completion
- Jun 15, 2028
Study Design
- Enrollment
- 30 participants (estimated)
Primary Outcome Measure
Esophageal Cancer resection in patients in high volume (more than 5 esophagectomy performed per year) and low volume (less than 5 esophagectomy performed per year) hospital facilities [ Time Frame: through study completion, up to 18 months ]
Central Contacts
- Crystee Cooper, DHEd214-947-1280
- Zaid Haddadin, MS214-947-1280
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Methodist Richardson Medical Center | Richardson | Texas | 75082 | Dhiresh Jeyarajah, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Richardson, TX
By condition
By specialty
By research site
Related Studies
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Merus B.V. · La Jolla, California
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaPHASE1/PHASE2 · Recruiting · VM Oncology, LLC · Santa Rosa, California
- Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid TumorsPHASE1 · Recruiting · Baylor College of Medicine · Houston, Texas
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyRecruiting · UMC Utrecht · Pittsburgh, Pennsylvania